ABIOMED, Inc. (ABMD) - Product Pipeline Analysis

ABIOMED, Inc. (ABMD) - Product Pipeline Analysis

Aug 2012 GlobalData Market Guide51 Pages Price :
$ 750

ABIOMED, Inc. (Abiomed) is a medical device company that focuses on the goal of establishing heart recovery against all acute cardiac attacks. It is a provider of heart support and recovery products used by healthcare professionals. Abiomed is the only company in the world that has an exclusive labeling on ventricular assist devices for all potentially recoverable heart failure indications. The company is one of the leading providers of products in the acute heart failure market and transports more number of ventricle assist devices (VADs) than any other company in the world.

In June 2012, the company received Health Canada approval to market the Impella cVAD device, a percutaneous Impella heart pump that provides peak flow of approximately 4 liters of blood per minute. In April 2012, the company also received CE Marking approval for Impella cVAD device.

The company operates in a single reportable segment namely, Research, Development and Sale of Medical Devices to support or replace the pumping function of the failing heart. Its products are utilized in a wide range of clinical settings by the heart surgeons for patients in profound shock and by the interventional cardiologists for patients who are in pre-shock.

This report is a source for data, analysis and actionable intelligence on the ABIOMED, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors’ pipeline products through review of the clinical trials, stage and phase of development, etc.
  • Which are the next high-value products that your competitor would add in its portfolio? – identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 4
List of Figures 5

ABIOMED, Inc. - Business Description 6

Key Facts 7
ABIOMED, Inc. - Major Products and Services 8
ABIOMED, Inc. Pipeline Products by Equipment Type 9
ABIOMED, Inc. Pipeline Products by Development Stage 11
ABIOMED, Inc. Pipeline Products by Therapy Area 13
ABIOMED, Inc. Pipeline Products by Trial Phase 15
ABIOMED, Inc. Pipeline Products by Milestone Summary 17
AbioCor II 19
AbioCor II Product Status 19
AbioCor II Product Description 19
AbioCor II Product Milestone 20
AbioCor II Product Patent Details 20
Impella cVAD 23
Impella cVAD Product Status 23
Impella cVAD Product Description 23
Impella cVAD Product Milestone 23
Impella cVAD Clinical Trial 24
Impella LP 2.5 - PCI 26
Impella LP 2.5 - PCI Product Status 26
Impella LP 2.5 - PCI Product Description 26
Impella LP 2.5 - PCI Clinical Trial 26
Impella Pediatric Pump 33
Impella Pediatric Pump Product Status 33
Impella Pediatric Pump Product Description 33
Impella RP 34
Impella RP Product Status 34
Impella RP Product Description 34
Impella RP Product Milestone 35
Symphony Heart Pump 36
Symphony Heart Pump Product Status 36
Symphony Heart Pump Product Description 36
Symphony Heart Pump Product Milestone 36
Symphony Heart Pump Clinical Trial 38
ABIOMED, Inc. - Key Competitors 41
ABIOMED, Inc. - Key Employees 42
ABIOMED, Inc. - Key Employee Biographies 43
ABIOMED, Inc. - Locations And Subsidiaries 44
Head Office 44
Other Locations & Subsidiaries 44
Recent Developments 45
ABIOMED, Inc., Recent Developments 45
Aug 02, 2012: Abiomed Reports Revenue Of $38.6m In Fiscal 2013 45
May 16, 2012: Abiomed Reports Revenue Of $126.4m In Fiscal 2012 45
Mar 21, 2012: Abiomed Appoints Susan Vissers Lisa As Senior Director Of Investor Relations And Corporate Development 46
Feb 03, 2012: Abiomed Reports Revenue Of $32.2m In Q3 Fiscal 2012 47
Dec 09, 2011: Abiomed Announces Expanded Heart Recovery Strategy With Multi Year Growth Initiatives 47
Dec 07, 2011: Abiomed To Release New Data And Product Updates At Investor & Analyst Day On December 9 48
Nov 09, 2011: PROTECT II Demonstrates That Patients Undergoing Extensive Revascularization Benefit The Most From Impella Support: Abiomed 48
Nov 07, 2011: Abiomed Announces Inclusion Of Hemodynamic Support With Impella In ACCF/AHA/SCAI 2011 49
Nov 03, 2011: Abiomed Reports Revenues Of $29.5m In Q2 Fiscal 2012 49
Oct 27, 2011: Abiomed To Release New Protect II Data And Economic Study Results At TCT 2011; Over 20 Impella Presentations Included In Show Schedule 50

Appendix 51
Methodology 51
About GlobalData 51
Contact Us 51
Disclaimer 51

List of Table


ABIOMED, Inc., Key Facts 1
ABIOMED, Inc. Key Pipeline Products by Equipment Type 1
ABIOMED, Inc. Key Pipeline Products by Therapy Area 1
ABIOMED, Inc. Key Pipeline Products by Development Stage 1
ABIOMED, Inc. Key Pipeline Products by Trial Phase 1
ABIOMED, Inc., Key Facts 7
ABIOMED, Inc., Major Products and Services 8
ABIOMED, Inc. Number of Pipeline Products by Equipment Type 9
ABIOMED, Inc. Pipeline Products by Equipment Type 10
ABIOMED, Inc. Number of Pipeline Products by Development Stage 11
ABIOMED, Inc. Pipeline Products by Development Stage 12
ABIOMED, Inc. Number of Pipeline Products by Therapy Area 13
ABIOMED, Inc. Pipeline Products by Therapy Area 14
ABIOMED, Inc. Number of Pipeline Products by Trial Phase 15
ABIOMED, Inc. Pipeline Products by Trial Phase 16
ABIOMED, Inc. Number of Pipeline Products By Milestone Summary 17
ABIOMED, Inc. Pipeline Products by Milestone Summary 18
AbioCor II - Product Status 19
AbioCor II - Product Description 19
AbioCor II - Product Milestone 20
AbioCor II - Patent Details1 20
AbioCor II - Patent Details2 21
AbioCor II - Patent Details3 22
Impella cVAD - Product Status 23
Impella cVAD - Product Description 23
Impella cVAD - Product Milestone 23
Impella cVAD - Effects of Advanced Mechanical Circulatory Support in Patients With ST Segment Elevation Myocardial Infarction Complicated by Cardiogenic Shock. The Danish Cardiogenic Shock Trial 24
Impella LP 2.5 - PCI - Product Status 26
Impella LP 2.5 - PCI - Product Description 26
Impella LP 2.5 - PCI - PROTECT II: A Prospective, Multi-Center, Randomized Controlled Trial of the IMPELLA RECOVER LP 2.5 System Versus Intra Aortic Balloon Pump (IABP)in Patients Undergoing Non Emergent High Risk PCI 26
Impella LP 2.5 - PCI - RECOVER II Trial: A Prospective Randomized Trial Investigating the Use of the IMPELLA RECOVER LP 2.5 System in Patients With Acute Myocardial Infarction Induced Hemodynamic Instability 28
Impella LP 2.5 - PCI - To Evaluate Safety And Feasibility Of Left Ventricular Support With The Impella 2.5 During High-Risk Percutaneous Coronary Intervention (PCI) And Treatment Of Acute Myocardial Infarction 29
Impella LP 2.5 - PCI - A Multi-Center, Randomized Trial Of The Impella Recover LP 2,5 (left ventricular assist) Device Versus Intra Aortic Balloon Counter Pulsation (IABP) Therapy For Large anterior Acute ST-Elevation Myocardial Infarction Patients Treated With Primary PCI 30
Impella Pediatric Pump - Product Status 33
Impella Pediatric Pump - Product Description 33
Impella RP - Product Status 34
Impella RP - Product Description 34
Impella RP - Product Milestone 35
Symphony Heart Pump - Product Status 36
Symphony Heart Pump - Product Description 36
Symphony Heart Pump - Product Milestone 36
Symphony Heart Pump - First in Man Study - a Prospective, Multicenter, Single Arm Trial to Investigate the Safety and Feasibility of the Symphony Device 38
ABIOMED, Inc., Key Employees 42
ABIOMED, Inc., Key Employee Biographies 43
ABIOMED, Inc., Subsidiaries 44

List of Chart


ABIOMED, Inc. Pipeline Products by Equipment Type 9
ABIOMED, Inc. Pipeline Products by Development Stage 11
ABIOMED, Inc. Pipeline Products by Therapy Area 13
ABIOMED, Inc. Pipeline Products by Trial Phase 15
ABIOMED, Inc. Pipeline Products by Milestone Summary 17

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report


Select License Type :

$ 750
$ 1500

Do you wish to check sample of this report?

Have Query?


Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top